Cwm, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Cwm, LLC
- $24.1 Billion
- Q4 2024
A detailed history of Cwm, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 13,191 shares of ALNY stock, worth $3.62 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,191
Previous 6,764
95.02%
Holding current value
$3.62 Million
Previous $1.86 Million
66.88%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding ALNY
# of Institutions
671Shares Held
109MCall Options Held
1.23MPut Options Held
1.18M-
Capital World Investors Los Angeles, CA16.5MShares$4.52 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.49 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.62 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.44 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.36 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...